Publications

Varnier, G. Pilkington, C.A., and Wedderburn L. R
Juvenile dermatomyositis : novel treatment approaches and outcomes.
Soponkanaporn, S. Deakin, C, T., Schutz, P, W., Marshall, L.R., Yasin, S, A., Johnson, C. M., Sag, E., Tansley, S, L., McHugh, N, J., Wedderburn, L, R. (2018).
Expression of Myxovirus-resistance Protein A: A Possible Marker of Muscle Disease Activity and Autoantibody Specificities in Juvenile Dermatomyositis.
Yasin, S, A., Schutz, P, W., Deakin, C, T., Sag, E., Varsani, H., Simou, S., Marshall, L, M., Tansley, S, L., McHugh, N, J., Holton, J, L., Wedderburn, L.R*., Jacques, T, S*., on behalf of the UK Juvenile Dermatomyositis Research Group (UK and Ireland) (2018). (*joint senior authors).
Histological heterogeneity in a large clinical cohort of juvenile idiopathic inflammatory myopathy: analysis by myositis autoantibody and pathological features.
Deakin, C.T. Campanilho-Marques, R., Simou, S., Moriatis, E., Wedderburn, L.R., Pullenayegum, E., and Pilkington, C. A. (2018).
Efficacy and safety of cyclophosphamide treatment in severe juvenile dermatomyositis shown by marginal structural modelling
McCann, L. J., Pilkington, C. A., Huber, A. M., Ravelli, A., Appelbe, D., Kirkham, J. J., Williamson, P. R., Aggarwal, A., Christopher-Stine, L., Constantine, T., Feldman, B., Lundberg, I., Maillard, S., Mathiesen, P., Murphy, R., Pachman, L. M., Reed, A., Rider, L. G., Van Royen-Kerkoff, A., Russo, R., Spinty, S., Wedderburn, L. R. & Beresford, M. W. (2018)
The development of an optimal core dataset set in Juvenile Dermatomyositis for clinical use to inform research
Lilleker, J. B., Vencovsky, J., Wang, G., Wedderburn, L. R., Diederichsen, L. P., Schmidt, J., Jordan, P., Benveniste, O., Danieli, M. G., Danko, K., Thuy, N, T, P., Vazquez-Del Mercado, M., Andersson, H., De Paepe, B., De Bleecker, J., Maurer, B., Pipitone, N., McHugh, N., Betteridge, Z., New, P., Cooper, R. G., Ollier, W, E., Lamb, J, A., Krogh, N, S., Lundberg, I, E., Chinoy, H., On behalf of all EuroMyositis contributors (2017).
Response to: ‘Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria
Lilleker, J. B., Vencovsky, J., Wang, G., Wedderburn, L. R., Pyndt Diederichsen, L., Schmidt, J., Oakley, P., Benveniste, O., Danieli, M. G., Danko, K., Phuong Thy, N. G., Vazquez-Del Mercado, M., Andersson, H., De Paepe, B., deBleecker, J. L., Maurer, B., McCann, L. J., Pipitone, N., McHugh, N., Betteridge, Z. E., New, P., Cooper, R. G., Ollier, W. E., Lamb, J. A., Krogh, N. S., Lundberg, I. E., Chinor, H., on behalf of all EuroMyositis Coordinators (2017).
The EuroMyositis registry: an international collaborative tool to facilitate myositis research. (2017).
Tansley, S. L., Simou, S., Shaddick, G., Betteridge, Z. E., Almeida, B., Gunawardena, H., Thomson, W., Beresford, M. W., Midgley, A., Muntoni, F., Wedderburn, L. R., & McHugh, N. J., on behalf of the JDRG (2017).
Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort
Enders, F.B., Bader-Meunier, B., Baildam, E., Constantin, T., Dolezalova, P., Feldman, B.M., Lahdenne, P., Magnusson, B., Nistala, K., Pilkington, C.A., Ozen, S., Ravelli, A., Russo, R., Uziel, Y., van Brussel, M., van der Net, J., Vastert, S., Wedderburn L.R., Wulffraat, N., McCann, L.J., and van Royen-Kerkhof, A (2017).
Consensus - Based Recommendations for the Management of Juvenile Dermatomyositis.
}))